(1->4)-beta-D-glucan multiple interactions ISO RGD:1557729 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAP4 mRNA CTD PMID:36331819 1,1-dichloroethene increases expression ISO RGD:1557729 6480464 vinylidene chloride results in increased expression of MAP4 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:1557729 6480464 1, 2-Dimethylhydrazine results in decreased expression of MAP4 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:1557729 6480464 Ethinyl Estradiol affects the expression of MAP4 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression ISO RGD:1557729 6480464 Ethinyl Estradiol results in increased expression of MAP4 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:1557729 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAP4 mRNA CTD PMID:17942748 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1343248 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1557729 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAP4 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MAP4 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1557729 6480464 Tetrachlorodibenzodioxin affects the expression of MAP4 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAP4 mRNA CTD PMID:21215274 , PMID:33387578 2,4,6-tribromophenol decreases expression ISO RGD:1343248 6480464 2 more ... CTD PMID:31675489 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1343248 6480464 tetrabromobisphenol A results in decreased expression of MAP4 protein CTD PMID:31675489 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1557729 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of MAP4 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1343248 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP4 mRNA CTD PMID:28628672 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of MAP4 mRNA CTD PMID:24780913 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of MAP4 mRNA CTD PMID:28959563 aflatoxin B1 decreases methylation ISO RGD:1343248 6480464 Aflatoxin B1 results in decreased methylation of MAP4 gene CTD PMID:27153756 aldrin increases expression ISO RGD:1557729 6480464 Aldrin results in increased expression of MAP4 mRNA CTD PMID:18579281 all-trans-retinoic acid decreases expression ISO RGD:1343248 6480464 Tretinoin results in decreased expression of MAP4 mRNA CTD PMID:33167477 antirheumatic drug increases expression ISO RGD:1343248 6480464 Antirheumatic Agents results in increased expression of MAP4 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1343248 6480464 aristolochic acid I results in decreased expression of MAP4 mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:1343248 6480464 Arsenic affects the methylation of MAP4 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1343248 6480464 Arsenic affects the methylation of MAP4 gene CTD PMID:25304211 benzatropine decreases expression ISO RGD:1343248 6480464 Benztropine results in decreased expression of MAP4 protein CTD PMID:34122009 benzene decreases expression ISO RGD:1343248 6480464 Benzene results in decreased expression of MAP4 mRNA CTD PMID:15929907 benzo[a]pyrene decreases expression ISO RGD:1343248 6480464 Benzo(a)pyrene results in decreased expression of MAP4 mRNA, Benzo(a)pyrene results in decreased expression of MAP4 protein CTD PMID:20064835 , PMID:32717239 benzo[a]pyrene increases methylation ISO RGD:1343248 6480464 Benzo(a)pyrene results in increased methylation of MAP4 5' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1343248 6480464 Benzo(a)pyrene affects the methylation of MAP4 3' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1557729 6480464 Benzo(a)pyrene results in increased methylation of MAP4 intron CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1557729 6480464 Benzo(a)pyrene results in decreased expression of MAP4 mRNA CTD PMID:19770486 , PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1343248 6480464 7 more ... CTD PMID:26238291 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1557729 6480464 Mustard Gas results in decreased expression of MAP4 mRNA CTD PMID:15674843 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MAP4 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1343248 6480464 bisphenol A results in decreased expression of MAP4 protein CTD PMID:31675489 bisphenol A increases methylation ISO RGD:1343248 6480464 bisphenol A results in increased methylation of MAP4 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1343248 6480464 bisphenol A results in increased expression of MAP4 protein CTD PMID:33024228 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MAP4 mRNA CTD PMID:30816183 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of MAP4 gene CTD PMID:28505145 Bisphenol B increases expression ISO RGD:1343248 6480464 bisphenol B results in increased expression of MAP4 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:1343248 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP4 mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:1343248 6480464 bisphenol F results in increased expression of MAP4 protein CTD PMID:34186270 Brodifacoum decreases expression EXP 6480464 bromfenacoum results in decreased expression of MAP4 protein CTD PMID:28903499 cadmium atom increases expression ISO RGD:1343248 6480464 Cadmium results in increased expression of MAP4 mRNA CTD PMID:24376830 cadmium atom multiple interactions ISO RGD:1343248 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MAP4 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1343248 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MAP4 mRNA CTD PMID:35301059 caffeine affects phosphorylation ISO RGD:1343248 6480464 Caffeine affects the phosphorylation of MAP4 protein CTD PMID:35688186 carbon nanotube decreases expression ISO RGD:1557729 6480464 Nanotubes, Carbon results in decreased expression of MAP4 mRNA CTD PMID:25620056 chlordecone decreases expression ISO RGD:1557729 6480464 Chlordecone results in decreased expression of MAP4 mRNA CTD PMID:33711761 chlormequat chloride decreases expression EXP 6480464 Chlormequat results in decreased expression of MAP4 protein CTD PMID:34958886 cisplatin decreases phosphorylation ISO RGD:1557729 6480464 Cisplatin results in decreased phosphorylation of MAP4 protein CTD PMID:22006019 cisplatin decreases expression ISO RGD:1343248 6480464 Cisplatin results in decreased expression of MAP4 mRNA CTD PMID:27594783 cobalt dichloride decreases expression ISO RGD:1343248 6480464 cobaltous chloride results in decreased expression of MAP4 mRNA CTD PMID:19320972 copper atom decreases expression ISO RGD:1343248 6480464 Copper results in decreased expression of MAP4 mRNA CTD PMID:16246896 copper(0) decreases expression ISO RGD:1343248 6480464 Copper results in decreased expression of MAP4 mRNA CTD PMID:16246896 coumarin decreases phosphorylation ISO RGD:1343248 6480464 coumarin results in decreased phosphorylation of MAP4 protein CTD PMID:35688186 CU-O LINKAGE increases phosphorylation ISO RGD:1343248 6480464 cupric oxide results in increased phosphorylation of MAP4 protein CTD PMID:25470785 cyclosporin A increases expression ISO RGD:1343248 6480464 Cyclosporine results in increased expression of MAP4 mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO RGD:1557729 6480464 Cyclosporine results in decreased expression of MAP4 mRNA CTD PMID:19770486 decabromodiphenyl ether increases expression ISO RGD:1343248 6480464 decabromobiphenyl ether results in increased expression of MAP4 protein CTD PMID:31675489 deoxynivalenol decreases phosphorylation ISO RGD:1557729 6480464 deoxynivalenol results in decreased phosphorylation of MAP4 protein CTD PMID:23811945 dexamethasone increases expression ISO RGD:1557729 6480464 Dexamethasone results in increased expression of MAP4 mRNA CTD PMID:17998272 dexamethasone multiple interactions ISO RGD:1343248 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP4 mRNA CTD PMID:28628672 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of MAP4 mRNA CTD PMID:21266533 dicrotophos increases expression ISO RGD:1343248 6480464 dicrotophos results in increased expression of MAP4 mRNA CTD PMID:28302478 dihydroartemisinin affects binding ISO RGD:1343248 6480464 artenimol analog binds to MAP4 protein modified form CTD PMID:26340163 dorsomorphin multiple interactions ISO RGD:1343248 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO RGD:1343248 6480464 Doxorubicin affects the expression of MAP4 protein CTD PMID:12006519 , PMID:29385562 doxorubicin decreases expression ISO RGD:1343248 6480464 Doxorubicin results in decreased expression of MAP4 mRNA CTD PMID:29803840 doxorubicin decreases expression ISO RGD:1557729 6480464 Doxorubicin results in decreased expression of MAP4 protein CTD PMID:12006519 elemental selenium increases expression ISO RGD:1343248 6480464 Selenium results in increased expression of MAP4 mRNA CTD PMID:19244175 enzyme inhibitor multiple interactions ISO RGD:1343248 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MAP4 protein CTD PMID:23301498 ethanol multiple interactions ISO RGD:1557729 6480464 Ethanol affects the expression of and affects the splicing of MAP4 mRNA CTD PMID:30319688 ethanol affects splicing ISO RGD:1557729 6480464 Ethanol affects the splicing of MAP4 mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1343248 6480464 Ethyl Methanesulfonate results in decreased expression of MAP4 mRNA CTD PMID:23649840 formaldehyde decreases expression ISO RGD:1343248 6480464 Formaldehyde results in decreased expression of MAP4 mRNA CTD PMID:23649840 genistein decreases expression ISO RGD:1343248 6480464 Genistein results in decreased expression of MAP4 mRNA, Genistein results in decreased expression of MAP4 protein CTD PMID:16705744 , PMID:20884965 genistein multiple interactions ISO RGD:1343248 6480464 ESR1 promotes the reaction [Genistein results in decreased expression of MAP4 protein], ESR2 promotes the reaction [Genistein results in decreased expression of MAP4 protein] CTD PMID:20884965 hydrogen peroxide multiple interactions ISO RGD:1557729 6480464 [Hydrogen Peroxide co-treated with N-(oxo-5 more ... CTD PMID:31494107 indometacin multiple interactions ISO RGD:1343248 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP4 mRNA CTD PMID:28628672 isotretinoin increases expression ISO RGD:1343248 6480464 Isotretinoin results in increased expression of MAP4 mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:1343248 6480464 Ivermectin results in decreased expression of MAP4 protein CTD PMID:32959892 lead(0) affects splicing ISO RGD:1343248 6480464 Lead affects the splicing of MAP4 mRNA CTD PMID:28903495 lead(2+) affects splicing ISO RGD:1343248 6480464 Lead affects the splicing of MAP4 mRNA CTD PMID:28903495 menadione affects expression ISO RGD:1343248 6480464 Vitamin K 3 affects the expression of MAP4 mRNA CTD PMID:20044591 mercury dibromide increases expression ISO RGD:1343248 6480464 mercuric bromide results in increased expression of MAP4 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1343248 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP4 mRNA CTD PMID:27188386 methamphetamine increases expression ISO RGD:1557729 6480464 Methamphetamine results in increased expression of MAP4 mRNA CTD PMID:26307267 methyl methanesulfonate decreases expression ISO RGD:1343248 6480464 Methyl Methanesulfonate results in decreased expression of MAP4 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1343248 6480464 methylmercuric chloride results in increased expression of MAP4 mRNA CTD PMID:28001369 N-nitrosodiethylamine increases expression ISO RGD:1557729 6480464 Diethylnitrosamine results in increased expression of MAP4 mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions ISO RGD:1557729 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MAP4 mRNA] CTD PMID:17854601 Nivalenol increases expression ISO RGD:1557729 6480464 nivalenol results in increased expression of MAP4 mRNA CTD PMID:35016910 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MAP4 mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:1557729 6480464 Acetaminophen affects the expression of MAP4 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1343248 6480464 Acetaminophen results in increased expression of MAP4 mRNA CTD PMID:29067470 paracetamol decreases expression ISO RGD:1343248 6480464 Acetaminophen results in decreased expression of MAP4 mRNA CTD PMID:21420995 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1557729 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAP4 mRNA CTD PMID:36331819 phenylmercury acetate increases expression ISO RGD:1343248 6480464 Phenylmercuric Acetate results in increased expression of MAP4 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1343248 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP4 mRNA CTD PMID:27188386 phosphorus atom increases expression ISO RGD:1343248 6480464 Phosphorus results in increased expression of MAP4 mRNA CTD PMID:17715259 phosphorus(.) increases expression ISO RGD:1343248 6480464 Phosphorus results in increased expression of MAP4 mRNA CTD PMID:17715259 pirinixic acid decreases expression ISO RGD:1557729 6480464 pirinixic acid results in decreased expression of MAP4 mRNA CTD PMID:17426115 pirinixic acid increases expression ISO RGD:1557729 6480464 pirinixic acid results in increased expression of MAP4 mRNA CTD PMID:23811191 potassium dichromate decreases expression ISO RGD:1557729 6480464 Potassium Dichromate results in decreased expression of MAP4 mRNA CTD PMID:23608068 pyrogallol increases expression ISO RGD:1557729 6480464 Pyrogallol results in increased expression of MAP4 mRNA CTD PMID:20362636 quercetin increases phosphorylation ISO RGD:1343248 6480464 Quercetin results in increased phosphorylation of MAP4 protein CTD PMID:35688186 resveratrol decreases expression ISO RGD:1343248 6480464 resveratrol results in decreased expression of MAP4 mRNA, resveratrol results in decreased expression of MAP4 protein CTD PMID:12569576 , PMID:18089832 SB 431542 multiple interactions ISO RGD:1343248 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom increases expression ISO RGD:1343248 6480464 Selenium results in increased expression of MAP4 mRNA CTD PMID:19244175 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of MAP4 mRNA CTD PMID:22431001 sodium arsenite increases expression ISO RGD:1557729 6480464 sodium arsenite results in increased expression of MAP4 protein CTD PMID:29044176 spermine increases expression ISO RGD:1557729 6480464 Spermine results in increased expression of MAP4 mRNA CTD PMID:18673383 tamoxifen affects expression ISO RGD:1557729 6480464 Tamoxifen affects the expression of MAP4 mRNA CTD PMID:17555576 tert-butyl hydroperoxide decreases expression ISO RGD:1343248 6480464 tert-Butylhydroperoxide results in decreased expression of MAP4 mRNA CTD PMID:15336504 thapsigargin increases expression ISO RGD:1557729 6480464 Thapsigargin results in increased expression of MAP4 protein CTD PMID:24648495 thimerosal decreases expression ISO RGD:1343248 6480464 Thimerosal results in decreased expression of MAP4 mRNA CTD PMID:27188386 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MAP4 mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:1343248 6480464 torcetrapib results in increased expression of MAP4 mRNA CTD PMID:23228038 trichloroethene decreases expression ISO RGD:1557729 6480464 Trichloroethylene results in decreased expression of MAP4 mRNA CTD PMID:19448997 triptonide affects expression ISO RGD:1557729 6480464 triptonide affects the expression of MAP4 mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:1343248 6480464 troglitazone results in increased expression of MAP4 mRNA CTD PMID:19140230 tungsten decreases expression ISO RGD:1557729 6480464 Tungsten results in decreased expression of MAP4 mRNA CTD PMID:30912803 valproic acid affects expression ISO RGD:1557729 6480464 Valproic Acid affects the expression of MAP4 mRNA CTD PMID:17292431 valproic acid multiple interactions ISO RGD:1343248 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP4 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1343248 6480464 Valproic Acid results in decreased expression of MAP4 mRNA CTD PMID:26272509 , PMID:28001369 valproic acid affects expression ISO RGD:1343248 6480464 Valproic Acid affects the expression of MAP4 mRNA CTD PMID:23179753 , PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of MAP4 mRNA CTD PMID:19015723 , PMID:23034163 vitamin E increases expression ISO RGD:1343248 6480464 Vitamin E results in increased expression of MAP4 mRNA CTD PMID:19244175 vorinostat decreases expression ISO RGD:1343248 6480464 vorinostat results in decreased expression of MAP4 mRNA CTD PMID:27188386 zinc atom increases expression ISO RGD:1343248 6480464 Zinc deficiency results in increased expression of MAP4 mRNA CTD PMID:12888634 zinc(0) increases expression ISO RGD:1343248 6480464 Zinc deficiency results in increased expression of MAP4 mRNA CTD PMID:12888634
